| 标题 |
Double-dose axicabtagene ciloleucel (Axi-Cel-2) as second-line therapy for high-risk relapsed or refractory large B-cell lymphoma (r/rLBCL): Interim results from a Phase 1b study |
| 网址 | |
| DOI |
10.1182/blood-2025-671
doi
|
| 其它 |
期刊:Blood 作者:Dasom (Caroline) Lee; Kameron Rodrigues; Masooma Rana; Kendall Kozy; Sunny Salazar; et al 出版日期:2025-12-05 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)